Document is current
Any future updates will be listed below
-
Authors
Mrdjen, Dunja
Cannon, Bryan J.
Amouzgar, Meelad https://orcid.org/0000-0003-0521-9223
Kim, YeEun https://orcid.org/0000-0003-3347-183X
Liu, Candace
Vijayaragavan, Kausalia
Camacho, Christine https://orcid.org/0000-0002-4924-591X
Spence, Angie
McCaffrey, Erin F.
Bharadwaj, Anusha
Tebaykin, Dmitry https://orcid.org/0000-0003-0913-8834
Bukhari, Syed
Bosse, Marc https://orcid.org/0000-0003-4912-8059
Hartmann, Felix J. https://orcid.org/0000-0002-4174-2276
Kagel, Adam
Oliveria, John Paul
Yakabi, Koya
Serrano, Geidy E.
Corrada, Maria M.
Kawas, Claudia H.
Tibshirani, Robert
Beach, Thomas G.
Corces, M. Ryan https://orcid.org/0000-0001-7465-7652
Greenleaf, Will https://orcid.org/0000-0003-1409-3095
Angelo, R. Michael https://orcid.org/0000-0003-1531-5067
Montine, Thomas https://orcid.org/0000-0002-1346-2728
Bendall, Sean C. https://orcid.org/0000-0003-1341-2453
- License Information
-
More Information
Article History
Received: 5 September 2023
Accepted: 23 May 2025
First Online: 22 July 2025
Competing interests
: S.C.B. and R.M.A. declare that they are consultants for and shareholders in Ionpath, which commercializes MIBI technology. S.C.B. and R.M.A. are inventors on and receive royalties for patents relating to MIBI technology licensed to Ionpath by Stanford. All other authors declare no competing interests.
